Meet the team
JAN TERJE ANDERSEN
CEO & Co-founder
Jan Terje is a leading expert on FcRn and its ligands.
Inventor of super albumin.
AINA KAREN ANTHI
CSO & Co-founder
Aina has a PhD in the use of super albumin as a carrier for therapeutics and subunit vaccines.
INGER SANDLIE
Chairman of the board & Co-founder
Inger is a leading expert on immune receptors, including FcRn.
Inventor of super albumin.
PETER HORN MØLLER
Board member & Co-founder
Peter is an expert on strategy, IP, licensing, partnerships and funding.
CHARLOTTE DYRING
Board member & Co-founder
Charlotte has extensive entrepreneurial experience in the pharmaceutical and biotech industries.
ERIK VINTHER
Board member & Co-founder
Erik has has extensive experience in taking early pharmaceutical development projects to marketed products.